Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-0.29
(-1.03%)
USD |
NASDAQ |
Oct 02, 16:00
27.80
+0.01
(+0.04%)
After-Hours: 20:00
Amylyx Pharmaceuticals Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -17.48K% |
| June 30, 2024 | |
| March 31, 2024 | -134.0% |
| December 31, 2023 | 4.36% |
| September 30, 2023 | 20.35% |
| June 30, 2023 | 22.48% |
| March 31, 2023 | 2.20% |
| December 31, 2022 | -195.1% |
| Date | Value |
|---|---|
| September 30, 2022 | -15.58K% |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | |
| September 30, 2021 | -8.12K% |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | -2.45K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc. | -1.64% |
| Eli Lilly & Co. | 30.88% |
| Merck & Co., Inc. | -8.06% |
| EyePoint, Inc. | -18.63K% |
| Bristol Myers Squibb Co. | 25.54% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -57.72% |
| Return on Assets | -52.46% |
| Return on Invested Capital | -56.49% |
| Return on Net Operating Assets | -2.74K% |